يعرض 1 - 10 نتائج من 469 نتيجة بحث عن '"MELISI, Davide"', وقت الاستعلام: 2.20s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: Morgagni , P , Bencivenga , M , Carneiro , F , Bertinoro Workshop Working Group , Cascinu , S , Derks , S , Di Bartolomeo , M , Donohoe , C , Eveno , C , Gisbertz , S , Grimminger , P , Gockel , I , Grabsch , H , Kassab , P , Langer , R , Lonardi , S , Maltoni , M , Markar , S , Moehler , M , Marrelli , D , Mazzei , M A , Melisi , D , Milandri , C , Moenig , P S ....

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المساهمون: Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione e del Merito, Ministero della Salute

    المصدر: Therapeutic Advances in Medical Oncology ; volume 16 ; ISSN 1758-8359 1758-8359

    مصطلحات موضوعية: Oncology

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: Procaccio, Letizia, Merz, Valeria, Fasano, Morena, Vaccaro, Vanja, Giommoni, Elisa, Pretta, Andrea, Noventa, Silvia, Satolli, Maria Antonietta, Giordano, Guido, Zichi, Clizia, Pinto, Carmine, Zecchetto, Camilla, Barsotti, Giulia, De Vita, Ferdinando, Milella, Michele, Antonuzzo, Lorenzo, Scartozzi, Mario, Zaniboni, Alberto, Spadi, Rosella, Casalino, Simona, Bergamo, Francesca, De Toni, Chiara, Melisi, Davide, Lonardi, Sara

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37278395; info:eu-repo/semantics/altIdentifier/wos/WOS:001004345400001; volume:12; issue:13; firstpage:14337; lastpage:14345; numberofpages:9; journal:CANCER MEDICINE; https://hdl.handle.net/11584/383931Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85161516408

  6. 6
    دورية أكاديمية

    المساهمون: Rimassa, Lorenza, Brandi, Giovanni, Niger, Monica, Normanno, Nicola, Melisi, Davide, Delphi Panel Member, Curti, Stefania

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37777074; info:eu-repo/semantics/altIdentifier/wos/WOS:001096709100001; volume:192; firstpage:1; lastpage:11; numberofpages:11; journal:CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY; https://hdl.handle.net/11585/959327Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85174894738; https://www.sciencedirect.com/science/article/abs/pii/S1040842823002342?via=ihubTest

  7. 7
    دورية أكاديمية

    المصدر: Augustinus , S , van Laarhoven , H W M , Cirkel , G A , de Groot , J W B , Groot Koerkamp , B , Macarulla , T , Melisi , D , O’Reilly , E M , van Santvoort , H C , Mackay , T M , Besselink , M G , Wilmink , J W & the Dutch Pancreatic Cancer Group 2023 , ' Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer : An International Expert Survey and Case-Vignette Study ' , Cancers , vol. 15 , no. ....

    وصف الملف: application/pdf

  8. 8
    دورية أكاديمية

    المساهمون: INSERM, Université de Lille, The University of Texas M.D. Anderson Cancer Center Houston, Vall d'Hebron University Hospital Barcelona, Institut Gustave Roussy IGR, Hospital Universitario 12 de Octubre Madrid, National Cancer Center Research Institute Tokyo, Humanitas University Milan Hunimed, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute Milan, St. Vincent's Hospital, Sydney, Calvary Mater Newcastle Hospital, Hopital Saint-Louis AP-HP AP-HP, University Hospital Wuerzburg / Universitäts­klinikum Würzburg, University of Louisville, Princess Margaret Hospital, Universitat de València UV, Centro de Investigación Biomédica en Red de Cáncer CIBERONC, CIC CHU ( Lille)/inserm, Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Eli Lilly and Company Indianapolis, Università degli studi di Verona = University of Verona UNIVR

    وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8

    العلاقة: Clinical Cancer Research; Clin Cancer Res; http://hdl.handle.net/20.500.12210/75054Test

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Wainberg ZA David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Melisi D Università degli studi di Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy. Macarulla T Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Pazo Cid R Hospital Universitario Miguel Servet, Zaragoza, Spain. Chandana SR Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA. De La Fouchardière C Centre Léon Bérard, Lyon, France, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: The Lancet;402(10409); https://doi.org/10.1016/S0140-6736Test(23)01366-1; Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardière C, et al. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet. 2023 Oct 7;402(10409):1272–81.; https://hdl.handle.net/11351/10436Test

  10. 10
    دورية أكاديمية